Immunohistochemical Expression of Upregulated Gene 4 Protein Expression (URG4/URGCP) and Its Association with 5-Year Survival in Patients with Colon Adenocarcinoma
Open Access
- 23 August 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (17) , 5477
Abstract
(1) Background: Colorectal cancer (CRC) is the third most common cancer in terms of incidence and mortality. Approximately 90% of all colorectal cancer cases are adenocarcinomas, originating from epithelial cells of the colorectal mucosa. Upregulated gene 4 (URG4) is an oncogene involved in cancer development. The aim of the study was to assess the immunohistochemical expression of URG4 protein expression in Polish patients with colon adenocarcinoma who were not treated with any therapy before radical surgery. (2) Methods: The study used colon tissue samples taken from people with a confirmed diagnosis of colorectal adenocarcinoma after a thorough histopathological examination. The associations between the immunohistochemical expression of URG4 and clinical parameters were analyzed by the Chi2 test or Chi2Yatesa test. The study conducted an analysis of the correlation between the expression of URG4 and the five-year survival rate of patients through the application of the Kaplan–Meier analysis and the log-rank statistical test. The intracellular localization of URG4 was identified through the utilization of transmission electron microscopy (TEM) methodology. (3) Results: In univariate Cox regression analyses, immuno-histochemical expression of URG4, grade of histological differentiation, depth of invasion, angioinvasion, PCNA expression, stage of disease and lymph node involvement were found to be significant prognostic factors. Within our patient cohort, it was observed that the degree of tumour differentiation and URG4 expression were found to be distinct prognostic factors in regard to the 5-year survival rates of those with colon adenocarcinoma. (4) Conclusions: High immunohistochemical expression of URG4 correlates with poor prognosis in patients with colon adenocarcinoma.Keywords
Funding Information
- Medical University of Silesia (PCN-1-151/K/2/I)
This publication has 27 references indexed in Scilit:
- Anti-proliferative and anti-invasive effects of ferulic acid in TT medullary thyroid cancer cells interacting with URG4/URGCPTumor Biology, 2015
- URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signalingOncotarget, 2015
- URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathwayBMC Cancer, 2015
- URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancerBMC Cancer, 2014
- Serological Identification of URGCP as a Potential Biomarker for GliomaCNS Neuroscience & Therapeutics, 2013
- Leukemogenesis as a new approach to investigate the correlation between up regulated gene 4/upregulator of cell proliferation (URG4/URGCP) and signal transduction genes in leukemiaMolecular Biology Reports, 2012
- The expression of URGCP gene in prostate cancer cell lines: correlation with rapamycinMolecular Biology Reports, 2012
- PCNA on the crossroad of cancerBiochemical Society Transactions, 2009
- Enhanced Cell Survival of Gastric Cancer Cells By a Novel Gene URG4Neoplasia, 2006
- Hepatitis Bx Antigen Stimulates Expression of a Novel Cellular Gene, URG4, that Promotes Hepatocellular Growth and SurvivalNeoplasia, 2002